Post Profile

'Game-changing' immunotherapy doubles head and neck cancer survival

(Institute of Cancer Research) An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer -- a disease which is notoriously difficult to treat.
read more


Related Posts

Chemoradiation May Increase Survival for a Subset of Elderly Head and Neck Cancer Patients

Health : Newswise Medical News

The addition of chemotherapy (CT) to radiation therapy (RT) improves survival rates among a subset of elderly head and neck cancer patients, specifically those ages 71 to 79 with low comorbidity scores and advanced disease stage, ac...

A new kind of treatment is working better than chemotherapy in some lung cancer patients (BMY, MRK)

Business & Finance : Business Insider: Money Game

For people with advanced forms of lung cancer, chemotherapy might not be the only — or even the best — option. The drug, marketed as Keytruda, is one of a new set of drugs called immunotherapy. The drug targets the programmed cell d...

Immunotherapy, Genomic Profiling and Potential Game Changing Drugs Lead List of 2014 Dana-Farber Research Highlights

Health : Newswise Medical News

Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.

Survival Improved In Multiple Myeloma Relapse By New Drug

Health : Medical News Today

Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs...

Immunotherapy drug a 'gamechanger' for head and neck cancer

Health : The Guardian: Health

Nivolumab found to extend lives of relapsed patients who had run out of therapy options An immunotherapy drug hailed as a potential “gamechanger” in the treatment of cancer could soon offer new hope to patients with currently untrea...


Copyright © 2016 Regator, LLC